These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31352053)

  • 21. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.
    Malcolm RK; Woolfson AD; Toner CF; Morrow RJ; McCullagh SD
    J Antimicrob Chemother; 2005 Nov; 56(5):954-6. PubMed ID: 16155060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
    Reddy K; Kelly C; Brown ER; Jeenarain N; Naidoo L; Siva S; Bekker LG; Nair G; Makanani B; Chinula L; Mgodi N; Chirenje Z; Kiweewa FM; Marrazzo J; Bunge K; Soto-Torres L; Piper J; Baeten JM; Palanee-Phillips T;
    AIDS; 2020 Mar; 34(4):559-567. PubMed ID: 31764068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of simulated vaginal and menstrual fluids to model
    McCoy CF; Spence P; Dallal Bashi YH; Murphy DJ; Boyd P; Dangi B; Derrick T; Devlin B; Kleinbeck K; Malcolm RK
    Int J Pharm X; 2021 Dec; 3():100081. PubMed ID: 34027386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.
    Nel A; Martins J; Bekker LG; Ramjee G; Masenga G; Rees H; van Niekerk N
    PLoS One; 2018; 13(5):e0196904. PubMed ID: 29813074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
    Nel A; Bekker LG; Bukusi E; Hellstrӧm E; Kotze P; Louw C; Martinson F; Masenga G; Montgomery E; Ndaba N; van der Straten A; van Niekerk N; Woodsong C
    PLoS One; 2016; 11(3):e0147743. PubMed ID: 26963505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings.
    Malcolm K; Woolfson D; Russell J; Tallon P; McAuley L; Craig D
    J Control Release; 2003 Jun; 90(2):217-25. PubMed ID: 12810304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques.
    Murphy DJ; Desjardins D; Boyd P; Dereuddre-Bosquet N; Stimmer L; Caldwell A; Le Grand R; Kelly C; van Roey J; Malcolm RK
    Int J Pharm; 2018 Oct; 550(1-2):300-308. PubMed ID: 30153490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention.
    Husnik MJ; Brown ER; Dadabhai SS; Gaffoor Z; Jeenarain N; Kiweewa FM; Livant E; Mansoor LE; Mirembe BG; Palanee-Phillips T; Singh D; Siva S; Soto-Torres L; van der Straten A; Baeten JM;
    AIDS Behav; 2021 Sep; 25(9):2801-2814. PubMed ID: 34117592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release-modulating factors strongly affecting steroid diffusion from silicone elastomer.
    Nash HA; Robertson DN; Evans SJ
    J Pharm Sci; 2004 Oct; 93(10):2420-30. PubMed ID: 15349952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Will dapivirine redeem the promises of anti-HIV microbicides? Overview of product design and clinical testing.
    das Neves J; Martins JP; Sarmento B
    Adv Drug Deliv Rev; 2016 Aug; 103():20-32. PubMed ID: 26732684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal rings for delivery of HIV microbicides.
    Malcolm RK; Fetherston SM; McCoy CF; Boyd P; Major I
    Int J Womens Health; 2012; 4():595-605. PubMed ID: 23204872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
    Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
    J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. U.S. Women Need the Dapivirine Ring, Too: FDA as Structural Barrier to HIV Prevention for Women.
    Gollub EL; Vaughan R
    AIDS Educ Prev; 2022 Aug; 34(4):311-324. PubMed ID: 35994576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
    Clark JT; Clark MR; Shelke NB; Johnson TJ; Smith EM; Andreasen AK; Nebeker JS; Fabian J; Friend DR; Kiser PF
    PLoS One; 2014; 9(3):e88509. PubMed ID: 24599325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method.
    Nelson AL
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):953-963. PubMed ID: 31526281
    [No Abstract]   [Full Text] [Related]  

  • 36. Transient analysis of drug delivery from a toroidal membrane: Applications for medicated vaginal rings.
    Simon L; Ospina J
    Eur J Pharm Sci; 2020 Jan; 141():105114. PubMed ID: 31655211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A temperature-monitoring vaginal ring for measuring adherence.
    Boyd P; Desjardins D; Kumar S; Fetherston SM; Le-Grand R; Dereuddre-Bosquet N; Helgadóttir B; Bjarnason Á; Narasimhan M; Malcolm RK
    PLoS One; 2015; 10(5):e0125682. PubMed ID: 25965956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dapivirine-releasing vaginal rings produced by plastic freeforming additive manufacturing.
    Welsh NR; Malcolm RK; Devlin B; Boyd P
    Int J Pharm; 2019 Dec; 572():118725. PubMed ID: 31648014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.
    McBride JW; Boyd P; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Malcolm RK
    J Control Release; 2019 Mar; 298():1-11. PubMed ID: 30731150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.